Biovitrum buys Swedish Orphan for SEK3.5bn in cash and stock
- Specialty Pharmaceuticals
- Payment Includes Cash
- Full Acquisition
- Includes Earnout
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.